{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T06:14:52Z","timestamp":1676096092479},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,8]],"date-time":"2008-03-08T00:00:00Z","timestamp":1204934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Care Manage Sci"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s10729-008-9056-9","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T01:57:40Z","timestamp":1204855060000},"page":"89-110","source":"Crossref","is-referenced-by-count":9,"title":["Requisite models for strategic commissioning: the example of type 1 diabetes"],"prefix":"10.1007","volume":"11","author":[{"given":"Mara","family":"Airoldi","sequence":"first","affiliation":[]},{"given":"Gwyn","family":"Bevan","sequence":"additional","affiliation":[]},{"given":"Alec","family":"Morton","sequence":"additional","affiliation":[]},{"given":"M\u00f3nica","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jenifer","family":"Smith","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,3,8]]},"reference":[{"key":"9056_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8510(94)00671-7","volume":"31","author":"J Ross","year":"1995","unstructured":"Ross J (1995) The use of economic evaluation in health care: Australian decision makers\u2019 perceptions. Health Policy 31:103\u2013110","journal-title":"Health Policy"},{"issue":"4","key":"9056_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0277-9536(96)00398-X","volume":"45","author":"MF Drummond","year":"1997","unstructured":"Drummond MF, Cooke J, Walley T (1997) Economic evaluation under managed competition: evidence from the U.K. Soc Sc Med 45(4):583\u2013595","journal-title":"Soc Sc Med"},{"key":"9056_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8510(98)00057-8","volume":"46","author":"T Duthie","year":"1999","unstructured":"Duthie T et al (1999) Research into the use of health economics in decision making in the United Kingdom\u2014Phase II Is health economics \u2018for good or evil\u2019? Health Policy 46:143\u2013157","journal-title":"Health Policy"},{"key":"9056_CR4","doi-asserted-by":"crossref","unstructured":"Drummond MF, Weatherly H (2000) Implementing the findings of health technology assessments. If the CAT got out of the bac, can the TAIL wag the dog? Int J Technol Assess Health Care 16(1):1\u201312","DOI":"10.1017\/S0266462300016111"},{"key":"9056_CR5","doi-asserted-by":"crossref","unstructured":"Bryan S, Williams I, McIver S (2007) Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. Health Econ 16:179\u2013193","DOI":"10.1002\/hec.1133"},{"key":"9056_CR6","unstructured":"Department of Health. PCT and SHA roles and functions (2006) http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_4134649 . Cited January 8, 2008"},{"key":"9056_CR7","unstructured":"Local Health System Integration Act (2006), Ontario"},{"key":"9056_CR8","doi-asserted-by":"crossref","unstructured":"Weinstein M, Stason W (1977) Foundation of cost-effectiveness analysis for health and medical practices. N Engl J Med 296:716\u2013721","DOI":"10.1056\/NEJM197703312961304"},{"key":"9056_CR9","doi-asserted-by":"crossref","unstructured":"Williams A (1985) Economics of coronary artery bypass grafting. Br Med J 291:326\u2013329","DOI":"10.1136\/bmj.291.6491.326"},{"key":"9056_CR10","unstructured":"Gold MR et al. (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York"},{"key":"9056_CR11","unstructured":"Drummond MF, et al (2005) Methods for the economic evaluation of health care programmes, third edition. Oxford University Press, Oxford"},{"issue":"6","key":"9056_CR12","first-page":"685","volume":"16","author":"MF Drummond","year":"2000","unstructured":"Anand S, Hanson K (1997) Disability-adjusted life years: a critical review. J Health Econ 16(6):685\u2013702","journal-title":"Int J Technol Assess Health Care"},{"key":"9056_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1050(199902)8:1<1::AID-HEC399>3.0.CO;2-B","volume":"8","author":"A Williams","year":"1999","unstructured":"Williams A (1999) Calculating the global burden of disease: time for a strategic reappraisal. Health Econ 8:1\u20138","journal-title":"Health Econ"},{"key":"9056_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-1050(200007)9:5<369::AID-HEC536>3.0.CO;2-D","volume":"9","author":"G Mooney","year":"2000","unstructured":"Mooney G, Wiseman V (2000) Burden of disease and priority setting. Health Econ 9:369\u2013372","journal-title":"Health Econ"},{"issue":"4","key":"9056_CR15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/14737167.3.4.469","volume":"3","author":"G Bevan","year":"2003","unstructured":"Bevan G, Hollinghurst S (2003) Cost per quality adjusted life year and disability adjusted life years: the need for a new paradigm. Expert Rev Pharmacoecon Outcomes Res 3(4):469\u2013477","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"9056_CR16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0167-6296(97)00004-0","volume":"16","author":"CJL Murray","year":"1997","unstructured":"Murray CJL, Acharya AK (1997) Understanding DALYs. J Health Econ 16:703\u2013730","journal-title":"J Health Econ"},{"key":"9056_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1099-1050(200001)9:1<69::AID-HEC493>3.0.CO;2-I","volume":"9","author":"CJL Murray","year":"2000","unstructured":"Murray CJL, Lopez AD (2000) Progress and directions in refining the Global Burden of Disease approach: a response to Williams. Health Econ 9:69\u201382","journal-title":"Health Econ"},{"key":"9056_CR18","volume-title":"Summary measures of population health: concepts, ethics, measurement and application","author":"AD Lopez","year":"2002","unstructured":"Lopez AD et al (2002) Summary measures of population health: concepts, ethics, measurement and application. World Health Organization, Geneva"},{"key":"9056_CR19","doi-asserted-by":"crossref","unstructured":"Hutubessy R, et al. (2003) Generalised cost-effectiveness analysis for national-level priority setting in the health sector. Cost Eff Resour Alloc 1:8","DOI":"10.1186\/1478-7547-1-8"},{"key":"9056_CR20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1192\/bjp.184.6.526","volume":"184","author":"G Andrews","year":"2004","unstructured":"Andrews G et al (2004) Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 184:526\u2013533","journal-title":"Br J Psychiatry"},{"key":"9056_CR21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.331.7525.1137","volume":"331","author":"D Evans","year":"2005","unstructured":"Evans D et al (2005) Methods to assess the costs and health effects of interventions for improving health in developing countries. Br Med J 331:1137\u20131140","journal-title":"Br Med J"},{"key":"9056_CR22","unstructured":"Dawson D, et al (2005) Developing new approaches to measuring NHS outputs and productivity. Report RP6, University of York Centre for Health Economics, York"},{"key":"9056_CR23","unstructured":"Department of Health (2005) Healthcare output and productivity: accounting for quality change. http:\/\/www.dh.gov.uk\/PublicationsAndStatistics\/Publications\/PublicationsPolicyAndGuidance\/PublicationsPolicyAndGuidanceArticle\/fs\/en?CONTENT_ID=4124266&chk=5QmbY7"},{"key":"9056_CR24","unstructured":"UK Centre for the Measurement of Government Activity (2006) Public service productivity: health. Econ Trends 628:26\u201357"},{"key":"9056_CR25","unstructured":"Martin S, Smith PC (2006) Value for money in the NHS. A summary of the evidence. C.f.H. Economics, Editor, University of York, York"},{"key":"9056_CR26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/bmj.331.7525.1133","volume":"331","author":"D Evans","year":"2005","unstructured":"Evans D et al (2005) Time to reassess strategies for improving health in developing countries. Br Med J 331:1133\u20131136","journal-title":"Br Med J"},{"issue":"1","key":"9056_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1019016702081","volume":"3","author":"S Hollinghurst","year":"2000","unstructured":"Hollinghurst S, Bevan G, Bowie C (2000) Estimating the \u201cavoidable\u201d burden of disease by Disability Adjusted Life Years (DALYs). Health Care Manage Sci 3(1):9\u201321","journal-title":"Health Care Manage Sci"},{"issue":"4","key":"9056_CR28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/14737167.3.4.469","volume":"3","author":"S Hollinghurst","year":"2003","unstructured":"Hollinghurst S, Bevan G (2003) A scientific revolution to resolve the incomplete paradigms of cost per quality adjusted life year and disability-adjusted life-years? Expert Rev Pharmacoecon Outcomes Res 3(4):469\u201377","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"9056_CR29","volume-title":"The South and West DALYs Project\u2014developing a powerful tool for health care planning","author":"G Bevan","year":"1998","unstructured":"Bevan G et al (1998) The South and West DALYs Project\u2014developing a powerful tool for health care planning. Somerset Health Authority, Taunton"},{"issue":"11","key":"9056_CR30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJM197603112941104","volume":"294","author":"D Rutstein","year":"1976","unstructured":"Rutstein D (1976) Measuring the quality of medical care. A clinical method. N Engl J Med 294(11):582\u2013588","journal-title":"N Engl J Med"},{"issue":"8326","key":"9056_CR31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(83)91981-5","volume":"321","author":"J Charlton","year":"1983","unstructured":"Charlton J et al (1983) Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. The Lancet 321(8326):691\u2013696","journal-title":"The Lancet"},{"key":"9056_CR32","unstructured":"Holland, W (1991) European Community Atlas of \u2018Avoidable Death\u2019\u2014Commission of the European Communities Health Services Research Series no. 6. Second edn, Vol. 1. In: W. Holland (ed). Oxford University Press, Oxford"},{"key":"9056_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1192\/bjp.184.6.526","volume":"184","author":"G Andrews","year":"2004","unstructured":"Andrews G et al (2004) Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 184:526\u2013533","journal-title":"Br J Psychiatry"},{"key":"9056_CR34","volume-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"T Tan-Torres Edejer","year":"2003","unstructured":"Tan-Torres Edejer T (2003) Making choices in health: WHO guide to cost-effectiveness analysis. W.H. Organization, Geneva"},{"key":"9056_CR35","unstructured":"Dawson D, et al (2005) Developing new approaches to measuring NHS outputs and productivity. CHE Research Paper (6). Centre for Health Economics, York, UK"},{"key":"9056_CR36","unstructured":"Tomar R, et al (1998) Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model. J Soc Health Syst 5(4):24\u201337"},{"issue":"3","key":"9056_CR37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0889-8529(05)70274-7","volume":"26","author":"W Herman","year":"1997","unstructured":"Herman W et al (1997) The cost-effectiveness of intensive therapy for diabetes mellitus. Endocrinol Metab Clin N Am 26(3):679\u2013695","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"9056_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s001250050003","volume":"43","author":"A Palmer","year":"2000","unstructured":"Palmer A et al (2000) The cost-effectiveness of different management strategies for Type I diabetes: a Swiss perspective. Diabetologia 43(1):13\u201326","journal-title":"Diabetologia"},{"issue":"17","key":"9056_CR39","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.1996.03540170053032","volume":"276","author":"Diabetes Control and Complication Trial","year":"1996","unstructured":"Diabetes Control and Complication Trial (1996) Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial.. JAMA 276(17):1409\u2013415","journal-title":"JAMA"},{"issue":"2","key":"9056_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1464-5491.2005.01787.x","volume":"23","author":"N Forouhi","year":"2006","unstructured":"Forouhi N et al (2006) Diabetes prevalence in England, 2001\u2014estimates from an epidemiological model. Diabet Med 23(2):189\u2013197","journal-title":"Diabet Med"},{"key":"9056_CR41","unstructured":"National Clinical Audit Support Programme. National Diabetes Audit (2005) Key findings about the quality of care for people with diabetes in England. Report for the audit period 2003\/04. http:\/\/www.icservices.nhs.uk\/ncasp\/pages\/audit_topics\/diabetes\/default-new.asp"},{"issue":"4","key":"9056_CR42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2337\/diacare.13.4.427","volume":"13","author":"Diabetes Control and Complication Trial","year":"1990","unstructured":"Diabetes Control and Complication Trial (1990) Diabetes control and complication trial update. Diabetes Care 13(4):427\u2013433","journal-title":"Diabetes Care"},{"issue":"14","key":"9056_CR43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Diabetes Control and Complication Trial","year":"1993","unstructured":"Diabetes Control and Complication Trial (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977\u2013986","journal-title":"N Engl J Med"},{"issue":"5","key":"9056_CR44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/diacare.20.5.735","volume":"20","author":"J Eastman","year":"1997","unstructured":"Eastman J et al (1997) Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 20(5):735\u2013744","journal-title":"Diabetes Care"},{"key":"9056_CR45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.320.7246.1373","volume":"320","author":"A Gray","year":"2000","unstructured":"Gray A et al (2000) Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 320:1373\u20131378","journal-title":"BMJ"},{"key":"9056_CR46","unstructured":"Stouthard M, et al (1997) Disability weights for diseases in The Netherlands. Rotterdam: Erasmus University, Department of Public Health"},{"key":"9056_CR47","unstructured":"National Institute for Health and Clinical Excellence (2007) The guidelines manual 2007. http:\/\/www.nice.org.uk\/page.aspx?o=422950"},{"key":"9056_CR48","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bmj.294.6585.1467","volume":"294","author":"I Wood","year":"1987","unstructured":"Wood I, Mallick N, Wing A (1987) Prediction of resources needed to achieve the national target for treatment of renal failure. BMJ 294:1467\u20131470","journal-title":"BMJ"},{"issue":"Supplement 4","key":"9056_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1464-5491.19.s4.2.x","volume":"19","author":"A Bagust","year":"2002","unstructured":"Bagust A et al (2002) The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. Diabet Med 19(Supplement 4):1\u20135","journal-title":"Diabet Med"},{"issue":"6","key":"9056_CR50","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1287\/opre.18.6.1021","volume":"18","author":"S Fanshel","year":"1970","unstructured":"Fanshel S, Bush J (1970) A health-status index and its application to health-services outcomes. Oper Res 18(6):1021\u20131066","journal-title":"Oper Res"},{"issue":"5","key":"9056_CR51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.20.5.725","volume":"20","author":"R Eastman","year":"1997","unstructured":"Eastman R (1997) Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 20(5):725\u2013734","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"9056_CR52","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1185\/030079904X1980","volume":"20","author":"A Palmer","year":"2004","unstructured":"Palmer A et al (2004) The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (type 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 20(Suppl. 1):S5\u2013S26","journal-title":"Curr Med Res Opin"},{"key":"9056_CR53","doi-asserted-by":"crossref","unstructured":"Mueller E, et al (2006) Development and validation of the economic assessment of glycemic control and long-term effects of diabetes (EAGLE) model. Diabetes Technol Ther 8(2):219\u2013236","DOI":"10.1089\/dia.2006.8.219"},{"key":"9056_CR54","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/diacare.26.11.3093","volume":"26","author":"DM Eddy","year":"2003","unstructured":"Eddy DM, Schlessinger L (2003) Archimedes: a trial-validated model of diabetes. Diabetes Care 26:3093\u20133101","journal-title":"Diabetes Care"},{"key":"9056_CR55","volume-title":"Tools for thinking. Modelling in management science, second edn","author":"M Pidd","year":"2003","unstructured":"Pidd M (2003) Tools for thinking. Modelling in management science, second edn. Wiley, Chichester"},{"key":"9056_CR56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0001-6918(84)90005-2","volume":"56","author":"L Phillips","year":"1984","unstructured":"Phillips L (1984) A theory of requisite decision models. Acta Psychol 56:29\u201348","journal-title":"Acta Psychol"},{"key":"9056_CR57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1464-5491.2000.00222.x","volume":"17","author":"C Morgan","year":"2000","unstructured":"Morgan C et al (2000) The prevalence of multiple diabetes-related complications. Diabet Med 17:146\u2013151","journal-title":"Diabet Med"},{"key":"9056_CR58","unstructured":"Department of Health (2004) Population figures at SHA and PCO level for England and Wales. www.dh.gov.uk\/assetRoot\/04\/11\/36\/62\/04113662.xls"},{"key":"9056_CR59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jech.56.1.18","volume":"56","author":"J Harvey","year":"2002","unstructured":"Harvey J, Craney L, Kelly D (2002) Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis. J Epidemiol Commun Health 56:18\u201323","journal-title":"J Epidemiol Commun Health"},{"issue":"6","key":"9056_CR60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1464-5491.1999.00075.x","volume":"16","author":"S Laing","year":"1999","unstructured":"Laing S et al (1999) The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16(6):459\u2013465","journal-title":"Diabet Med"},{"issue":"6","key":"9056_CR61","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1464-5491.1999.00076.x","volume":"16","author":"S Laing","year":"1999","unstructured":"Laing S et al (1999) The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16(6):466\u2013471","journal-title":"Diabet Med"},{"issue":"4","key":"9056_CR62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-005-0120-4","volume":"49","author":"S Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu S et al (2006) All-cause mortality rates in patients with Type 1 diabetes mellitus compared to a non-diabetic population from the General Practice Research Database (GPRD) 1992\u20131999. Diabetologia 49(4):660\u2013666","journal-title":"Diabetologia"},{"issue":"4","key":"9056_CR63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","volume":"29","author":"S Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu S et al (2006) High Risk of Cardiovascular Disease in Patients with Type 1 Diabetes in the U.K. A cohort study using the General Practice Research Database. Diabetes Care 29(4):798\u2013804","journal-title":"Diabetes Care"},{"key":"9056_CR64","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.313.7060.779","volume":"313","author":"P Rossing","year":"1996","unstructured":"Rossing P et al (1996) Predictors of mortality in insulin dependend diabetes: 10-year observational follow-up study. Br Med J 313:779\u2013784","journal-title":"Br Med J"},{"key":"9056_CR65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF00281993","volume":"28","author":"K Borch-Johnsen","year":"1985","unstructured":"Borch-Johnsen K, Andersen P, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590\u2013596","journal-title":"Diabetologia"},{"key":"9056_CR66","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.1992.00400150120022","volume":"152","author":"S Moss","year":"1992","unstructured":"Moss S, Klein R, Klein B (1992) The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 152:610\u2013616","journal-title":"Arch Intern Med"},{"key":"9056_CR67","first-page":"959","volume":"161","author":"D Thompson","year":"1999","unstructured":"Thompson D, Kozak S, Sheps S (1999) Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial. Can Med Assoc J 161:959\u2013962","journal-title":"Can Med Assoc J"},{"issue":"8","key":"9056_CR68","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/(SICI)1096-9136(199708)14:8<686::AID-DIA434>3.0.CO;2-D","volume":"14","author":"C Currie","year":"1997","unstructured":"Currie C et al (1997) NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabet Med 14(8):686\u2013692","journal-title":"Diabet Med"},{"key":"9056_CR69","volume-title":"UK Renal Registry. The Sixth Annual Report","author":"D Ansell","year":"2003","unstructured":"Ansell D et al (2003) UK Renal Registry. The Sixth Annual Report. The Renal Association, Bristol"},{"key":"9056_CR70","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.eye.6701476","volume":"18","author":"R Williams","year":"2004","unstructured":"Williams R et al (2004) Epidemiology of diabetic retinopathy and macula oedema: a systematic review. Eye 18:963\u2013983","journal-title":"Eye"},{"key":"9056_CR71","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1057\/palgrave.jors.2600890","volume":"51","author":"R Davies","year":"2000","unstructured":"Davies R et al (2000) Using simulation modelling for evaluating screening services for diabetic retinopathy. J Oper Res Soc 51:476\u2013484","journal-title":"J Oper Res Soc"},{"issue":"6","key":"9056_CR72","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc07-9919","volume":"30","author":"Mount Hood 4 Modeling Group","year":"2007","unstructured":"Mount Hood 4 Modeling Group (2007) Computer modeling of diabetes and its complications. Diabetes Care 30(6):1638\u20131646","journal-title":"Diabetes Care"},{"key":"9056_CR73","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/diacare.27.4.901","volume":"27","author":"MM Ortegon","year":"2004","unstructured":"Ortegon MM, Redekop WK, Niessen LW (2004) Cost-effectiveness of prevention and treatment of the diabetic foot. A Markov analysis. Diabetes Care 27:901\u2013907","journal-title":"Diabetes Care"},{"key":"9056_CR74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1464-5491.2006.02057.x","volume":"24","author":"C Currie","year":"2007","unstructured":"Currie C et al (2007) The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 24:187\u2013194","journal-title":"Diabet Med"},{"key":"9056_CR75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1056-8727(03)00035-7","volume":"18","author":"A Gordois","year":"2004","unstructured":"Gordois A et al (2004) The health care costs of diabetic nephropaty in the United States and the United Kingdom. J Diabetes Complicat 18:18\u201326","journal-title":"J Diabetes Complicat"},{"key":"9056_CR76","first-page":"62","volume":"6","author":"A Gordois","year":"2003","unstructured":"Gordois A et al (2003) The health care costs of diabetic peripheral neuropathy in the United Kingdom. The Diabetic Foot 6:62\u201373","journal-title":"The Diabetic Foot"},{"key":"9056_CR77","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archopht.1994.01090210105023","volume":"112","author":"R Klein","year":"1994","unstructured":"Klein R (1994) The Wisconsin Epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217\u20131228","journal-title":"Arch Ophthalmol"},{"key":"9056_CR78","first-page":"1799","volume":"102","author":"R Klein","year":"1998","unstructured":"Klein R (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type1 diabetes. Ophthalmology 102:1799\u20131800","journal-title":"Ophthalmology"},{"key":"9056_CR79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archopht.1989.01070010243030","volume":"107","author":"R Klein","year":"1989","unstructured":"Klein R (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30\u00a0years. Arch Ophthalmol 107:237\u2013243","journal-title":"Arch Ophthalmol"},{"key":"9056_CR80","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1989.01070010250031","volume":"107","author":"R Klein","year":"1989","unstructured":"Klein R (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is greater than 30 years. Arch Ophthalmol 107:244\u2013249","journal-title":"Arch Ophthalmol"},{"key":"9056_CR81","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archinte.1989.00390020016004","volume":"149","author":"R Klein","year":"1989","unstructured":"Klein R et al (1989) Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266\u2013267","journal-title":"Arch Intern Med"},{"key":"9056_CR82","doi-asserted-by":"crossref","unstructured":"Colquitt J, et al. (2004) Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 8(43):1\u2013186","DOI":"10.3310\/hta8430"},{"key":"9056_CR83","doi-asserted-by":"crossref","unstructured":"MacLeod A, et al. (1998) Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews. Health Technol Assess 2(5):1\u2013166","DOI":"10.3310\/hta2050"},{"key":"9056_CR84","volume-title":"What could be nicer than NICE?","author":"A Williams","year":"2004","unstructured":"Williams A (2004) What could be nicer than NICE? Office of Health Economics, London"},{"key":"9056_CR85","unstructured":"Bevan, G., et al (2007) Estimating health and productivity gains in England from selected interventions. Research report, The Health Foundation"},{"key":"9056_CR86","unstructured":"Diabetes UK (2004) The national paediatric diabetes audit. Results from the audit year 2002. http:\/\/www.bsped.org.uk\/professional\/diabetesuk\/NationalPaediatricAudit.pdf"},{"key":"9056_CR87","unstructured":"Diabetes UK (2004) Diabetes in the UK 2004. A report from Diabetes UK"},{"key":"9056_CR88","unstructured":"Health and Social Care Information Centre (2004) Quality and Outcomes Framework. http:\/\/www.ic.nhs.uk\/services\/qof"},{"key":"9056_CR89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1019086300747","volume":"1","author":"S. Brailsford","year":"1998","unstructured":"Brailsford S et al (1998) Evaluating screening policies for the early detection of retinopathy in patients with non-insulin dependent diabetes. Health Care Manage Sci 1:115\u2013124","journal-title":"Health Care Manage Sci"},{"key":"9056_CR90","unstructured":"Brailsford S et al (2001) Screening for diabetic retinopathy. The evaluation of screening policies for diabetic retinopathy using computer simulation. http:\/\/www.management.soton.ac.uk\/retinopathy\/ last updated 25 October 2001. Date of last access 13 November 2007"},{"key":"9056_CR91","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1057\/palgrave.jors.2600890","volume":"51","author":"R. Davies","year":"2000","unstructured":"Davies R et al (2000) Using simulation modelling for evaluating screening services for diabetic retinopathy. J Oper Res Soc 51: 476\u2013484","journal-title":"J Oper Res Soc"},{"key":"9056_CR92","unstructured":"Niessen L (2002) Roads to health. Multi-state modelling of population health and resource use. Dutch University Press"},{"key":"9056_CR93","unstructured":"Office of National Statistics (2003) Mortality statistics. Cause. Series DH2, no. 30"},{"key":"9056_CR94","doi-asserted-by":"crossref","unstructured":"Mowatt G et al (2003) Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 7(2)","DOI":"10.3310\/hta7020"},{"key":"9056_CR95","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.2003.00972.x","volume":"20","author":"P Clarke","year":"2003","unstructured":"Clarke P et al (2003) The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS study No. 65). Diabetic Medicine 20:442\u2013450","journal-title":"Diabetic Medicine"},{"key":"9056_CR96","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1464-5491.2001.00630.x","volume":"18","author":"J Harvey","year":"2001","unstructured":"Harvey, J et al (2001) Population-based survey and analysis of trends in the prevalence of diabetic nephropathy in Type 1 diabetes. Diabet Med 18:998\u20131002","journal-title":"Diabetic Medicine"},{"key":"9056_CR97","unstructured":"DARTS (2001) DARTS annual report, Tayside: Tayside University Hospital"},{"issue":"14","key":"9056_CR98","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.294.14.1782","volume":"294","author":"P Finne","year":"2005","unstructured":"Finne P et al (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294(14):1782\u20131787","journal-title":"JAMA"},{"key":"9056_CR99","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R et al (1984) The Wisconsin Epidemiologic study of diabetic retinopathy. Arch Ophthalmol 102:520\u2013526","journal-title":"Arch Ophthalmol"},{"key":"9056_CR100","unstructured":"HM Treasury (2003) The Green Book: appraisal and evaluation in central Government. London: TSO"}],"container-title":["Health Care Management Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-008-9056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10729-008-9056-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-008-9056-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:47:59Z","timestamp":1559242079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10729-008-9056-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,8]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9056"],"URL":"https:\/\/doi.org\/10.1007\/s10729-008-9056-9","relation":{},"ISSN":["1386-9620","1572-9389"],"issn-type":[{"value":"1386-9620","type":"print"},{"value":"1572-9389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,8]]}}}